Latest On-Demand Webinars

Speaking at the Vaccine Research & Development 2022, Kyle Luttgeharm, PhD, Product Manager from Agilent presented their talk on IVT RNA production and
accurate and precise mRNA analysis.

Speaking at the Vaccine Research & Development 2022, Jorge Armero Gimenez from Wageningen University & Research, presented their talk on Virus-Like Particles immunogenicity in human dendritic cells.

The scientific experience is fundamental to the success and efficiency of the entire laboratory ecosystem. Scientists need to be able to focus on their critical work and not be burdened by challenges such as siloed data, manual processes and old technology.

Artificial Intelligence (AI) and Machine Learning (ML) are rapidly entering the day-to-day operations of many organizations, and data efforts are in full force.

The Problem
LNPs are a valuable tool in the repertoire of gene and vaccine delivery vectors but LNP development is a complex multi-step process.

During this webinar, you will understand how capillary electrophoresis (CE) and LC-MS are being used to ensure vaccine and cell and gene therapy product quality. We will discuss how LC-MS is being used to identify impurities present in lipid nanoparticle (LNP) vaccines that have been found to deactivate mRNA. We will also cover how CE is being used in viral vector production to ensure product quality.

Join us for an exclusive panel discussion focused on research and development relating to novel chemical entities in the psychedelics industry and some of the viable business models that are emerging in this field.

This Technology Networks event features exclusive talks focused on the most recent and innovative developments in the world of cell and gene therapies. Our expert speakers will highlight the opportunities cell and gene therapies provide for the treatment of disease and injury, including how cell therapies are providing novel solutions for rare diseases such as Duchenne muscular dystrophy.

Far too many forays into managed lab services focus purely on reducing the existing cost of service. While cost reductions can and should be one of the arrows in the service providers’ quiver, it shouldn’t be the only one…or the most important one.

A well-designed and implemented managed services program should be one that grows value over time and constantly evolves to ensure that clients are able to spend more time focused on their core scientific activities.

This webinar will be a helpful exercise for key stakeholders to help them get past the basic economics of selecting a provider and help guide them into partnerships that accelerate adoption and unmask far greater and more impactful value.

This exclusive Technology Networks webinar focuses on the most recent and innovative strategies for therapeutic antibody development and production. Your speaker, Professor Brockwell, will describe the development and use of a new assay to investigate important proteins in disease screening and the biopharmaceutical industry.